New study shows a minimum dose of hydromethylthionine could slow cognitive decline

ABERDEEN, Scotland and Singapore, 26 November, 2019 – In a paper published in today’s online issue of the Journal of Alzheimer’s Disease (DOI 10.3233/JAD-190772), TauRx has reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels and pharmacological activity of the drug hydromethylthionine on the brain in over 1,000 patients…

NewPneu, a cost-effective system for diagnosing childhood pneumonia in low-res

Oakville, Ontario: A device designed by a team of faculty and student researchers at Sheridan’s Centre for Mobile Innovation (CMI) has the potential to impact the diagnosis of community-acquired pneumonia – a significant cause of death for children worldwide, according to the World Health Organization. NewPneu is a mobile health solution that’s cost-effective, portable, easy…